Jupiter Topco LLC Takes $793,000 Position in CorVel Corp. $CRVL

Jupiter Topco LLC bought a new position in CorVel Corp. (NASDAQ:CRVL) during the 2nd quarter, Holdings Channel reports. The fund bought 12,699 shares of the business services provider’s stock, valued at approximately $793,000.

A number of other hedge funds also recently made changes to their positions in the company. Royal Bank of Canada boosted its stake in CorVel by 12.5% during the first quarter. Royal Bank of Canada now owns 51,261 shares of the business services provider’s stock valued at $5,739,000 after buying an additional 5,703 shares during the last quarter. AQR Capital Management LLC increased its stake in CorVel by 4.0% in the 1st quarter. AQR Capital Management LLC now owns 26,468 shares of the business services provider’s stock worth $2,964,000 after acquiring an additional 1,013 shares during the last quarter. Integrated Wealth Concepts LLC raised its holdings in shares of CorVel by 11.4% during the 1st quarter. Integrated Wealth Concepts LLC now owns 3,800 shares of the business services provider’s stock worth $425,000 after acquiring an additional 389 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of CorVel by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,846 shares of the business services provider’s stock worth $1,774,000 after acquiring an additional 702 shares in the last quarter. Finally, Millennium Management LLC raised its holdings in shares of CorVel by 127.4% during the 1st quarter. Millennium Management LLC now owns 48,182 shares of the business services provider’s stock worth $5,395,000 after acquiring an additional 26,990 shares in the last quarter. 51.36% of the stock is currently owned by hedge funds and other institutional investors.

CorVel Stock Performance

CRVL opened at $68.23 on Monday. The firm has a market cap of $3.48 billion, a P/E ratio of 30.32 and a beta of 0.97. CorVel Corp. has a 12 month low of $44.83 and a 12 month high of $93.45. The stock has a 50-day moving average of $64.25 and a 200 day moving average of $59.06.

CorVel (NASDAQ:CRVL) last issued its quarterly earnings data on Tuesday, August 4th. The business services provider reported $0.63 earnings per share for the quarter. CorVel had a return on equity of 29.92% and a net margin of 11.72%.The company had revenue of $259.93 million for the quarter.

Insider Buying and Selling

In other CorVel news, insider Maxim Shishin sold 2,250 shares of CorVel stock in a transaction on Friday, June 12th. The shares were sold at an average price of $60.59, for a total transaction of $136,327.50. Following the completion of the transaction, the insider directly owned 7,050 shares of the company’s stock, valued at $427,159.50. The trade was a 24.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director R. Jessup sold 4,023 shares of the business’s stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $70.07, for a total transaction of $281,891.61. Following the transaction, the director owned 111,798 shares in the company, valued at $7,833,685.86. This trade represents a 3.47% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 20,197 shares of company stock worth $1,315,568. 39.72% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

CRVL has been the subject of a number of recent research reports. Wall Street Zen raised shares of CorVel from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Weiss Ratings raised shares of CorVel from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, September 1st. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Hold”.

CorVel Company Profile

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).